Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Dec 11

PMID 36497503

Authors

Shuzhi Lin

Ningsheng Wang

Biqi Ren

Shuang Lei

Bianling Feng

Affiliations

Soon will be listed here.

Abstract

It is crucial to investigate the risk factors inherent in the medication process for cancer patients since improper antineoplastic drug use frequently has serious consequences. As a result, the Severity, Occurrence, and Detection rate of each potential failure mode in the drug administration process for patients with lung cancer were scored using the Failure Mode and Effect Analysis (FMEA) model in this study. Then, the risk level of each failure mode and the direction of improvement were investigated using the Slacks-based measure data envelopment analysis (SBM-DEA) model. According to the findings, the medicine administration process for lung cancer patients could be classified into five links, with a total of 60 failure modes. The risk of failure modes for patient medication and post-medication monitoring ranked highly, with unauthorized use of traditional Chinese medicine and folk prescription and unauthorized drug addition (incorrect self-medication) ranking first (1/60); doctor prescription was also prone to errors. The study advises actively looking at ways to decrease the occurrence and difficulty of failure mode detection to continually enhance patient safety when using medications.

Citing Articles

Healthcare Application of Failure Mode and Effect Analysis (FMEA): Is There Room in the Infectious Disease Setting? A Scoping Review.

Vecchia M, Sacchi P, Marvulli L, Ragazzoni L, Muzzi A, Polo L Healthcare (Basel). 2025; 13(1).

PMID: 39791689 PMC: 11719677. DOI: 10.3390/healthcare13010082.

Using the Failure Mode and Effect Analysis Tool to Improve the Automatic Stop Order Process.

Al Mardawi G, Rajendram R, Balharith A, Alomaim A Glob J Qual Saf Healthc. 2024; 7(4):197-206.

PMID: 39534236 PMC: 11554394. DOI: 10.36401/JQSH-24-9.

References

Ashley L, Dexter R, Marshall F, McKenzie B, Ryan M, Armitage G . Improving the safety of chemotherapy administration: an oncology nurse-led failure mode and effects analysis. Oncol Nurs Forum. 2011; 38(6):E436-44. DOI: 10.1188/11.ONF.E436-E444. View

Liu H, Zhang L, Ping Y, Wang L . Failure mode and effects analysis for proactive healthcare risk evaluation: A systematic literature review. J Eval Clin Pract. 2019; 26(4):1320-1337. DOI: 10.1111/jep.13317. View

Drach-Zahavy A, Somech A, Admi H, Peterfreund I, Peker H, Priente O . (How) do we learn from errors? A prospective study of the link between the ward's learning practices and medication administration errors. Int J Nurs Stud. 2013; 51(3):448-57. DOI: 10.1016/j.ijnurstu.2013.06.010. View

Asaad Assiri G, Shebl N, Mahmoud M, Aloudah N, Grant E, Aljadhey H . What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018; 8(5):e019101. PMC: 5942474. DOI: 10.1136/bmjopen-2017-019101. View

Anjalee J, Rutter V, Samaranayake N . Application of failure mode and effects analysis (FMEA) to improve medication safety in the dispensing process - a study at a teaching hospital, Sri Lanka. BMC Public Health. 2021; 21(1):1430. PMC: 8293514. DOI: 10.1186/s12889-021-11369-5. View

Al-Surimi K, Alwabel A, Bawazir A, Shaheen N . Road towards promoting patient safety practices among hospital pharmacists: Hospital-based baseline patient safety culture assessment cross-sectional survey. Medicine (Baltimore). 2021; 100(2):e23670. PMC: 7808443. DOI: 10.1097/MD.0000000000023670. View

Weingart S, Zhang L, Sweeney M, Hassett M . Chemotherapy medication errors. Lancet Oncol. 2018; 19(4):e191-e199. DOI: 10.1016/S1470-2045(18)30094-9. View

Reinhardt H, Otte P, Eggleton A, Ruch M, Wohrl S, Ajayi S . Avoiding chemotherapy prescribing errors: Analysis and innovative strategies. Cancer. 2019; 125(9):1547-1557. DOI: 10.1002/cncr.31950. View

Schwappach D, Wernli M . Am I (un)safe here? Chemotherapy patients' perspectives towards engaging in their safety. Qual Saf Health Care. 2010; 19(5):e9. DOI: 10.1136/qshc.2009.033118. View

10.

Wang N, Ren B, You H, Chen Y, Lin S, Lei S . Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross-sectional study. Health Expect. 2022; 25(2):791-801. PMC: 8957719. DOI: 10.1111/hex.13426. View

11.

Huertas-Fernandez M, Martinez-Bautista M, Rodriguez-Mateos M, Zarzuela-Ramirez M, Munoz-Lucero T, Baena-Canada J . Implementation of safeguards to improve patient safety in chemotherapy. Clin Transl Oncol. 2017; 19(9):1099-1106. DOI: 10.1007/s12094-017-1645-y. View

12.

Schwappach D, Wernli M . Barriers and facilitators to chemotherapy patients' engagement in medical error prevention. Ann Oncol. 2010; 22(2):424-30. DOI: 10.1093/annonc/mdq346. View

13.

Denny D, Allen D, Worthington N, Gupta D . The use of failure mode and effect analysis in a radiation oncology setting: the Cancer Treatment Centers of America experience. J Healthc Qual. 2012; 36(1):18-28. DOI: 10.1111/j.1945-1474.2011.00199.x. View

14.

Robinson D, Heigham M, Clark J . Using Failure Mode and Effects Analysis for safe administration of chemotherapy to hospitalized children with cancer. Jt Comm J Qual Patient Saf. 2006; 32(3):161-6. DOI: 10.1016/s1553-7250(06)32021-1. View

15.

Tudor Car L, Papachristou N, Urch C, Majeed A, Atun R, Car J . Prioritizing medication safety in care of people with cancer: clinicians' views on main problems and solutions. J Glob Health. 2017; 7(1):011001. PMC: 5475313. DOI: 10.7189/jogh.07.011001. View

16.

Alharbi W, Cleland J, Morrison Z . Exploring healthcare professionals' perceptions of medication errors in an adult oncology department in Saudi Arabia: A qualitative study. Saudi Pharm J. 2019; 27(2):176-181. PMC: 6362166. DOI: 10.1016/j.jsps.2018.10.001. View

17.

Hayes C, Jackson D, Davidson P, Power T . Medication errors in hospitals: a literature review of disruptions to nursing practice during medication administration. J Clin Nurs. 2015; 24(21-22):3063-76. DOI: 10.1111/jocn.12944. View

18.

Diaz Del Campo P, Gracia J, Blasco J, Andradas E . A strategy for patient involvement in clinical practice guidelines: methodological approaches. BMJ Qual Saf. 2011; 20(9):779-84. DOI: 10.1136/bmjqs.2010.049031. View

19.

Ashley L, Armitage G . Failure mode and effects analysis: an empirical comparison of failure mode scoring procedures. J Patient Saf. 2011; 6(4):210-5. DOI: 10.1097/pts.0b013e3181fc98d7. View

20.

Hammoudi B, Ismaile S, Abu Yahya O . Factors associated with medication administration errors and why nurses fail to report them. Scand J Caring Sci. 2017; 32(3):1038-1046. DOI: 10.1111/scs.12546. View